Testing for ESR1 Mutations to Guide Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer …
HJ Burstein, A DeMichele, MR Somerfield… - Journal of Clinical …, 2023 - ascopubs.org
ASCO Rapid Recommendations Updates highlight revisions to select ASCO guideline
recommendations as a response to the emergence of new and practice-changing data. The …
recommendations as a response to the emergence of new and practice-changing data. The …
Testing for ESR1 Mutations to Guide Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer …
HJ Burstein, A DeMichele… - Journal of Clinical …, 2023 - ingentaconnect.com
ASCO Rapid Recommendations Updates highlight revisions to select ASCO guideline
recommendations as a response to the emergence of new and practice-changing data. The …
recommendations as a response to the emergence of new and practice-changing data. The …
Testing for ESR1 Mutations to Guide Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: ASCO …
HJ Burstein, A DeMichele… - Journal of clinical …, 2023 - pubmed.ncbi.nlm.nih.gov
ASCO Rapid Recommendations Updates highlight revisions to select ASCO guideline
recommendations as a response to the emergence of new and practice-changing data. The …
recommendations as a response to the emergence of new and practice-changing data. The …